Sight Sciences (SGHT) Research & Development (2020 - 2026)
Sight Sciences' (SGHT) quarterly Research & Development came in at $2.5 million in Q1 2026, down 42.53% year-on-year from $4.4 million in Q1 2025, and up 4.47% quarter-over-quarter from $2.4 million in Q4 2025.
Sight Sciences (SGHT) Research & Development (2020 - 2026) Analysis & Trends
Sight Sciences' Research & Development history runs 7 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- On a quarterly basis, Research & Development fell 42.53% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $12.7 million, a 28.47% decrease from a year earlier, with the FY2025 full-year figure at $14.6 million, down 18.81% from the prior year.
- Research & Development climbed to $2.5 million in Q1 2026 per SGHT's latest filing, from $2.4 million in the prior quarter.
- Across five years, Research & Development topped out at $6.1 million in Q3 2022 and bottomed at $2.4 million in Q4 2025.
- The 5-year median for Research & Development is $4.4 million (2025), against an average of $4.4 million.
- Across the five-year window, Research & Development jumped 67.12% in 2022 and tumbled 43.23% in 2025, its largest moves.
- Year by year, Research & Development stood at $5.2 million in 2022, then sank by 34.51% to $3.4 million in 2023, then rose by 25.27% to $4.3 million in 2024, then tumbled by 43.23% to $2.4 million in 2025, then increased by 4.47% to $2.5 million in 2026.
- Per Business Quant, the three latest SGHT Research & Development figures stand at $2.5 million (Q1 2026), $2.4 million (Q4 2025), and $3.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -461.27 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Sight Sciences | 253.53 Mn | 168.57 Mn | 16.98 Mn | 2.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.55 Mn |
| Dec 31, 2025 | 2.44 Mn |
| Sep 30, 2025 | 3.35 Mn |
| Jun 30, 2025 | 4.39 Mn |
| Mar 31, 2025 | 4.43 Mn |
| Dec 31, 2024 | 4.29 Mn |
| Sep 30, 2024 | 4.75 Mn |
| Jun 30, 2024 | 4.32 Mn |
| Mar 31, 2024 | 4.64 Mn |
| Dec 31, 2023 | 3.43 Mn |
| Sep 30, 2023 | 4.24 Mn |
| Jun 30, 2023 | 5.22 Mn |
| Mar 31, 2023 | 4.67 Mn |
| Dec 31, 2022 | 5.23 Mn |
| Sep 30, 2022 | 6.05 Mn |
| Jun 30, 2022 | 5.93 Mn |
| Mar 31, 2022 | 5.65 Mn |
| Dec 31, 2021 | 4.37 Mn |
| Sep 30, 2021 | 4.28 Mn |
| Jun 30, 2021 | 3.55 Mn |